Medscape on iPhone and iPod Touch
 

Multimedia: Video and SlideShows

Previous
Forward
  • Rethinking Screening Mammography Rethinking Screening Mammography   What is the controversy about screening mammograms according to a recently published JAMA study? Dr. Andrew Kaunitz discusses if you should still recommend breast cancer screening in this video blog.
    Kaunitz on Women's Health, November 2009
  • The Medscape Cancer Survivorship Survey The Medscape Cancer Survivorship Survey   In his latest video blog, Dr. Maurie Markman encourages viewers to participate in the Medscape survey for healthcare providers that discusses cancer survivor care.
    Markman on Oncology, November 2009
  • Joint Pain Associated With Aromatase Inhibitors in Patients With Breast Cancer Joint Pain Associated With Aromatase Inhibitors in Patients With Breast Cancer   In her latest video blog, Dr. Kathy Miller comments on a new study examining the incidence of arthralgia associated with aromatase inhibitor therapy in patients with breast cancer.
    Miller on Oncology, November 2009
  • Will There Ever Be a Big Brown Ribbon Outside the White House? Will There Ever Be a Big Brown Ribbon Outside the White House?   In his latest video blog, Dr. John Marshall questions why the pink ribbon/breast cancer awareness promotion attracts more publicity than any other disease campaign.
    Marshall on Oncology, November 2009
  • Can Doctors Ever Tell Patients They Are Cured of Cancer? Can Doctors Ever Tell Patients They Are Cured of Cancer?   In her first Medscape video blog, Dr. Kathy Miller asks whether doctors should avoid using the term cured to describe patients who have been in remission for several years.
    Miller on Oncology, November 2009
  • Using SERMs to Prevent Breast Cancer Using SERMs to Prevent Breast Cancer   What are the benefits and risks of SERMs in the primary prevention of invasive breast cancer in high-risk women? Dr. Andrew Kaunitz discusses the results of a systematic review in this video blog.
    Kaunitz on Women's Health, October 2009
  • The Value of Final Exams The Value of Final Exams   In his latest video blog, Dr. John Marshall compares the work involved in writing successful grant proposals to the preparations necessary for final exams.
    Marshall on Oncology, October 2009
  • Dose-Dense Paclitaxel and Carboplatin in Ovarian Cancer Dose-Dense Paclitaxel and Carboplatin in Ovarian Cancer   A weekly regimen provided longer progression-free survival and overall survival than standard treatment in patients with ovarian cancer. Dr. Maurie Markman summarizes the Sept. 20 Lancet article.
    Markman on Oncology, September 2009
  • PET Scan vs CT Scan in NSCLC Staging and Genetic Testing for Warfarin PET Scan vs CT Scan in NSCLC Staging and Genetic Testing for Warfarin   In this video blog, Dr. Andy Shorr discusses a study on the use of the PET scan and the CT scan in the staging of NSCLC. He also provides insight into the pharmacogenetics of warfarin.
    Shorr on Pulmonary Medicine, September 2009
  • How Safe Is the HPV Vaccine? How Safe Is the HPV Vaccine?   Dr. Maurie Markman highlights the results of a surveillance study on the safety of the HPV vaccine in his latest video blog.
    Markman on Oncology, August 2009
  • Tweaking Adjuvant Strategies for Pancreatic Cancer Tweaking Adjuvant Strategies for Pancreatic Cancer   In this video blog, Dr. John Marshall explains how administration of available drugs, plus or minus radiation, might be modified to improve prognosis for patients with resected pancreatic cancer.
    Marshall on Oncology, August 2009
  • Colon Cancer Screening: Is It Only a Swallow Away? Colon Cancer Screening: Is It Only a Swallow Away?   Will colon capsule endoscopy replace colonoscopy for colorectal cancer screening? David A. Johnson, MD, discusses the pros and cons of this emerging technology in his latest video blog.
    Johnson on Gastroenterology, August 2009

Community Blogs

More Community Blogs

Physician Connect

More Discussions
All Clinical Discussions
 

Commentary and Interviews

More Commentary and Interviews

POLL

A recent study found that the use of erythropoiesis-stimulating agents (ESAs) in cancer patients on chemotherapy increased their risk for venous thromboembolism and did not reduce blood transfusions, which was the intended use for ESAs. How often do you use ESAs for your cancer patients?
A. Always
B. Sometimes
C. Not very often
D. Not often at all
or  View Results
Related Link: Related Medscape Article
 
 
 
 
Latest from NCCN at
Medscape.com/NCCN
Latest from Susan G. Komen
for the Cure at
Medscape.com/Komen

Also of Interest

 

Guidelines in the News

 

Business of Medicine

 

Genomics

More Genomics Articles
 
 
Medscape    MedscapeCME    eMedicine    Drugs    MEDLINE    All
All material on this website is protected by copyright, Copyright © 1994-2009 by Medscape. This website also contains material copyrighted by 3rd parties.